Page 3 - Abbott Alinity News Today

FreeStyle Libre system brought by Abbott, a global healthcare leader, is a first-of-its-kind wearable sensor-based technology that gave people with...

On March 12, 2021, Abbott, a global healthcare leader launched the FreeStyle Libre system in Vietnam

Abbott has achieved CE Mark for the i-STAT TBI Plasma test, the first rapid handheld traumatic brain injury (TBI) blood plasma test, which permits marketing in the European Union and will help clinicians assess individuals with suspected mild TBIs, including concussions. Click to read more...

A daily roundup of news on COVID-19 and the rest of medicine

Singapore News - Abbott Alinity Covid-19 test kits that were recalled as potentially false positive results were supplied in Singapore for use in clinical laboratories, said the Health Sciences Authority (HSA) yesterday. The clinical laboratories were informed last month of the potential... Read more at www.tnp.sg

A daily roundup of news on COVID-19 and the rest of medicine

Track breaking Flu Pandemics headlines on NewsNow: the one-stop shop for Flu Pandemics news

Curative changes to only nasal COVID-19 tests July 25, 2021 FacebookTwitterEmail Curative testing site specialist Mercedes Aguirre, inside booth, gives instructions Wednesday, Feb. 3, 2021 to a person for a self-administered COVID-19 coronavirus test on the opening day of Curatives Beacon Hill testing site. Curative operates about a dozen testing sites in the San Antonio area according to the companys website.William Luther, Staff / William Luther As COVID-19 cases begin to climb again and more...

High individual-level variability in SARS-CoV-2 shedding may explain superspreading Researchers in the United States have provided a high-resolution description of the viral dynamics involved in acute infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19). The team’s daily longitudinal sampling of 60 newly infected individuals revealed that significant person-to-person variation in the shedding of infectious vi...

Frequent testing improves the detection of SARS-CoV-2 Detecting SARS-CoV-2, the virus that causes COVID-19, improves with regularity of testing, whether using rapid antigen tests or PCR molecular tests. The PCR test is considered the gold standard for diagnosing COVID-19 infection, but cost and infrastructure issues, as well as wait times for PCR results, have limited its use more broadly as a screening tool for asymptomatic people because rapid results are needed to interrupt the chain of tran...